Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.49% | $208.89M | $543.52B | 97.45% | 81 Outperform | |
| Roche Holding AG | 1.05% | $147.58M | CHF270.26B | 48.10% | 73 Outperform | |
| HSBC Holdings | 1.05% | $146.24M | £216.17B | 51.15% | 80 Outperform | |
| AstraZeneca | 0.95% | $133.08M | £209.44B | 18.97% | 80 Outperform | |
| Shell (UK) | 0.89% | $124.37M | £154.84B | 5.05% | 73 Outperform | |
| Royal Bank Of Canada | 0.85% | $119.04M | $233.77B | 36.77% | 75 Outperform | |
| Nestlé SA | 0.83% | $115.71M | CHF183.47B | 11.82% | 71 Outperform | |
| Novartis | 0.70% | $98.60M | $282.84B | 42.16% | 80 Outperform | |
| SAP SE | 0.67% | $93.23M | €223.32B | -38.35% | 66 Neutral | |
| Toyota Motor | 0.65% | $91.52M | ¥43.62T | 15.97% | 80 Outperform |